Health Care

AbbVie Inc Chief Executive Richard Gonzalez on Wednesday promised to keep all drug price increases in 2017 under 10 percent, becoming the third global drugmaker to publicly make that pledge.

The Homeland Security Department is warning the public about an unusual cybersecurity flaw for one manufacturer's implantable heart devices that could allow hackers to remotely take control of a person's defibrillator or pacemaker.

The latest on developments in financial markets (All times local): 9:35 a.m.

Chipotle says a key sales figure turned positive last month, a possible sign that the burrito chain may be starting to recover from a food safety scare.

Valeant Pharmaceuticals International is selling its Dendreon cancer treatment business and three skincare brands for $2.12 billion as the troubled Canadian drugmaker looks to reduce more than $30 billion in debt.

Health care giant Johnson & Johnson plans next month to disclose price increases of its prescription drugs as the industry tries to calm the storm over soaring prices.

As President Barack Obama prepares to deliver his farewell address Tuesday night, he will attempt one final time to assign meaning to his presidency in front of a nation that overwhelmingly voted to usher in an era of change. As the full range of powers associated with the executive branch is transferred into Trump’s hands, the President-elect will begin to undo Obama's legacy starting with these executive orders.

Valeant is selling three skincare brands to L'Oréal for $1.3 billion.

The Pennsylvania-based maker of Cold-Eeze throat lozenges has announced that it has sold the brand to another pharmaceutical company for $50 million.

L'Oreal is acquiring three specialized skincare brands - CeraVe, AcneFree and Ambi - from Valeant Pharmaceuticals for $1.3 billion.

A Twitter suspension could find its way into the hands of the prosecution, here's how...

Japanese drugmaker Takeda Pharmaceutical has agreed to buy U.S. cancer drug developer Ariad Pharmaceuticals in a $4.7 billion deal.

One of the deadliest cancers in the United States can now be detected in the privacy of your own home.

During an interview with the FOX Business Network’s Maria Bartiromo, California Republican lawmaker Darryl Issa provided detailed analysis of Hillary Clinton’s email probe.

A repeal of Obamacare would set off mass confusion and chaos, Kathleen Sebelius , the Secretary of Health and Human Services under President Obama, said Wednesday.

Allergan CEO Brent Saunders says drug price increases have to stop. During an interview with the FOX Business Network’s Maria Bartiromo he discussed Allergan’s “social contract with patients” to cap drug prices.

Ben Brafman told FOX Business he's 'represented personalities a lot more difficult' than former drug CEO Martin Shkreli.

In a wide-ranging interview with FOX Business Network’s Maria Bartiromo, GOP Presidential Candidate Donald Trump said he will be releasing a comprehensive tax reform plan over the next four weeks that would cut taxes.

With a record run in the stock market, deals might be few and far between, but Omega Advisors CEO Leon Cooperman said stocks are still the place to be.